Protagonist Therapeutics Inc. | Key People and Executives
Dinesh V. Patel
President, CEO & Executive Director
Harold E. Selick
Chairman
Sarah Noonberg
Independent Director
Bryan Giraudo
Independent Director
Lewis T. Williams
Independent Director
William D. Waddill
Independent Director
Chaitan S. Khosla
Independent Director
Armen B. Shanafelt
Independent Director
Dinesh V. Patel
President, CEO & Executive Director
Thomas P. O'Neil
Chief Financial & Accounting Officer
Richard S. Shames
Chief Medical Officer
David Y. Liu
CSO, Head-Research & Development
Mark L. Smythe
Vice President-Technology
Samuel R. Saks
Chief Development Officer
Lucio Tozzi
Senior Director-Clinical Operations
Thamil Annamalai
Senior Director-Preclinical Development
Ashok Bhandari
Senior Director-Chemistry
Larry Mattheakis
Senior Director-Biology
Niall Murphy
Vice President & Controller
Harold E. Selick
Chairman
Sarah Noonberg
Independent Director
Bryan Giraudo
Independent Director
Lewis T. Williams
Independent Director
William D. Waddill
Independent Director
Chaitan S. Khosla
Independent Director
Armen B. Shanafelt
Independent Director
| Address |
7707 Gateway Boulevard
Newark California 94560
United States
|
|
Employees
|
- |
| Website |
http://www.protagonist-inc.com |
| Updated |
07/08/2019 |
| Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It offers proprietary peptide technology platform, which discovers and develops new chemical entities to address significant unmet medical needs. The firm's initial lead product candidates, PTG-100 and PTG-200, are being developed for moderate-to-severe ulcerative colitis and Crohn's disease, respectively. |
